Swiss drugs regulator approves first bivalent Covid-19 booster
- World
- Reuters
- Published Date: 01:30 | 29 August 2022
- Modified Date: 01:34 | 29 August 2022
Swiss drugs regulator Swissmedic said on Monday that it has approved the first bivalent Covid-19 booster vaccine in the country.
Moderna's Spikevax vaccine, which contains mRNA against two coronavirus variants, is authorized for anyone 18 years or older, said Swissmedic.
- Russia-Ukraine confidence building 'going well': FM Çavuşoğlu
- Russia struggles to recruit soldiers for Ukraine: Pentagon
- Top pro-Russian official shot dead in Ukraine's southern Kherson region
- United States urges 'controlled shutdown' of Zaporizhzhia plant
- White House calls for 'dialogue' after 'disturbing' unrest in Iraq